(USA)
The world’s leading biotechnology trade body will hold the 20th edition of its annual CEO & Investor Conference in 2018.
More than 800 investors have already signed up to take part in the two-day event on 13 and 14 February, which is organised by the Biotechnology Innovation Organization (BIO). Dozens of countries will be represented at what is one of the industry’s ‘largest investor conferences’.
Register now for the Conference – which will be held at the New York Marriott Marquis.
And for industry stakeholders more focussed on Europe, the Bio-based Industries Consortium (BIC) released a new report this week outlining the range of financial support that is available to advance large-scale projects across the continent.
“Bioeconomy investments are crucial to reduce Europe’s dependence on non-renewable resources and to make our economy more sustainable. BIC’s report is a practical guide for anyone looking to invest in the bioeconomy, providing a breakdown of applicable instruments and co-funding opportunities, ranging from debt and equity to quasi-equity financing and grants. BIC continues to provide its members with vital information on how to access capital and mobilise investment in bio-based developments,” said
Dirk Carrez, Executive Director of BIC.
